Ultralife(US:ULBI)2026-03-10 13:32Financial Data and Key Metrics Changes - Q4 revenue reached $48.5 million, a 10.6% increase year-over-year, with an operating loss of $10.6 million resulting in a loss of $0.45 EPS [5][7] - Full year revenue for 2025 was $191.2 million, with over $30 million from new products, marking a 16.2% year-over-year growth, leading to a full year operating loss of $5.9 million and a loss of $0.35 EPS [5][6] - Consolidated gross profit was $12.1 million, up 13.7% from the previous year, with a gross margin of 24.9%, a 70 basis point improvement [9][10] Business Line Data and Key Metrics Changes - Battery and energy product segment revenues were $45.9 million, a 15.1% increase year-over-year, with organic growth driven by a 39.6% increase in medical and a 20.4% increase in industrial and other commercial sectors [7][8] - Communications Systems segment revenues declined to $2.6 million, a 35.2% decrease from the previous year, primarily due to delayed orders [8][9] Market Data and Key Metrics Changes - The sales split for the battery business was 73% commercial and 27% government defense, compared to 70% and 30% respectively in the previous year [8] - The backlog at the end of Q4 was $110.2 million, a 22.1% increase from the previous quarter, representing 58% of trailing twelve months sales [9][10] Company Strategy and Development Direction - The company aims to improve the profitability of its Communications Systems business and enhance gross margins in the battery and energy segment [16][17] - Strategic initiatives include transitioning to a unified brand, consolidating operations, and focusing on vertical integration opportunities following the acquisition of Electrochem [18][19] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth potential in 2026, citing a healthy backlog and several new product launches [6][25] - The company is targeting organic growth rates of at least double GDP and aims for EBITDA margins greater than 10% in the short term [27][28] Other Important Information - The company completed its ERP transition and operational initiatives to reduce costs during 2025 [5][6] - The transition of various sub-brands to the Ultralife master brand is expected to streamline operations and reduce costs [19][25] Q&A Session Summary Question: Growth and Margin Expansion Goals - Management indicated a roadmap to achieve organic growth and aims for a minimum of 2x GDP growth, targeting over 10% EBITDA margins in the short term [27] Question: Baseline Revenue for Communications Systems - Baseline revenue for the Communications Systems business is defined as $25 million, with potential for larger orders in the future [29] Question: Medical Order Ramp-Up - A new medical order is expected to generate a six-figure revenue stream annually, with initial product launches beginning soon [30][31]